Adam Gibb, Craig Jones, Adrian Bloor, Samar Kulkarni, Tim Illidge, Kim Linton and John Radford (2013) “Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single UK center”, Haematologica. Pavia, Italy, 98(4), pp. 611-614. doi: 10.3324/haematol.2012.069393.